Nuzenio

Immunotherapy Trials

Immunotherapy Trials news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 7 latest news signals 6 publisher sources 100/100 entity strength

Latest news

FDA Clears Bria-PROS+ Immunotherapy Trial in Prostate Cancer - Targeted OncologyTargeted Oncology · Fri, 07 Aug 2026 00:45:35 GMTTransformational $20 million commitment will support UNC Lineberger’s Cellular Immunotherapy Program - UNC NewsUNC News · Thu, 06 Aug 2026 17:42:04 GMTCancer-Inspired Immunotherapy for Alzheimer’s Just Passed First Human Safety Test - StudyFindsStudyFinds · Wed, 05 Aug 2026 07:44:01 GMTKarine Tawagi Highlights Bladder Preservation and Immunotherapy Trials at BCANTT26 - OncodailyOncodaily · Fri, 31 Jul 2026 19:02:08 GMTAlliance QUANTUM trial to study bispecific immunotherapy for rare leukemia - EurekAlert!EurekAlert! · Thu, 30 Jul 2026 20:07:21 GMTThe Clues Hidden in Failed Prostate Cancer Immunotherapy Trials - MedscapeMedscape · Tue, 28 Jul 2026 10:45:31 GMTPhase 2 CHIMERA Trial Tests Neoadjuvant Pembrolizumab in Mesothelioma - Targeted OncologyTargeted Oncology · Mon, 27 Jul 2026 07:00:00 GMT

Timeline

Fri, 07 Aug 2026 00:45:35 GMTFDA Clears Bria-PROS+ Immunotherapy Trial in Prostate Cancer - Targeted Oncology
Thu, 06 Aug 2026 17:42:04 GMTTransformational $20 million commitment will support UNC Lineberger’s Cellular Immunotherapy Program - UNC News
Wed, 05 Aug 2026 07:44:01 GMTCancer-Inspired Immunotherapy for Alzheimer’s Just Passed First Human Safety Test - StudyFinds
Fri, 31 Jul 2026 19:02:08 GMTKarine Tawagi Highlights Bladder Preservation and Immunotherapy Trials at BCANTT26 - Oncodaily
Thu, 30 Jul 2026 20:07:21 GMTAlliance QUANTUM trial to study bispecific immunotherapy for rare leukemia - EurekAlert!
Tue, 28 Jul 2026 10:45:31 GMTThe Clues Hidden in Failed Prostate Cancer Immunotherapy Trials - Medscape

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Immunotherapy Trials.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

6 distinct publisher/source names are currently connected to this entity page.